A Rutgers University study found that metformin reduces exercise-related gains in blood vessel function, aerobic fitness and ...

A 50-year-old Indian expat in Dubai narrowly escaped permanent vision loss after sudden visual disturbances led to the ...

Diabetes often arrives quietly. It begins as subtle shifts in body chemistry that if left unchecked, can alter lives. Today, ...

ICMR reports that 56% of chronic diseases in India are linked to unhealthy diets and poor lifestyle choices The Indian ...

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules discovered using ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two companies are ...

Detailed price information for Ford Motor Company (F-N) from The Globe and Mail including charting and trades.

FDA End-of-Phase 2 meeting for pilavapadin in DPNP to be held by year-end All IND-enabling studies of LX9851 for obesity completed and submitted ...

Gilead Sciences, Inc. today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab govitecan-hziy) versus chemotherapy as a first-line treatment post-endocrine therapy in ...

Science continues to uncover the intricate connections between the brain, body, and behavior. From new insights into mental ...